You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Peptide-Drug Conjugate (PDC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Biopsy
  • +3 more
  • (no location specified)
Jan 18, 2023

Advanced Solid Tumor, Breast Cancer, Non Small Cell Lung Cancer Trial (MB1707)

Not yet recruiting
  • Advanced Solid Tumor
  • +4 more
  • (no location specified)
Jul 18, 2022

Solid Tumor, TNBC - Triple-Negative Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in United States (TH1902)

Recruiting
  • Solid Tumor
  • +8 more
  • Los Angeles, California
  • +5 more
Jun 27, 2022

Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States

Recruiting
  • Breast Adenocarcinoma
  • +7 more
  • Multi-epitope HER2 Peptide Vaccine TPIV100
  • +5 more
  • Scottsdale, Arizona
  • +26 more
Aug 17, 2022

Prostate Cancer Trial in Oslo (TENDU)

Recruiting
  • Prostate Cancer
  • TENDU
  • Oslo, Norway
    Oslo University Hospital, The Norwegian Radium Hospital
Mar 29, 2022

Relapsed and/or Refractory Multiple Myeloma Trial in United States (Melphalan Flufenamide, Dexamethasone)

Approved for marketing
  • Relapsed and/or Refractory Multiple Myeloma
  • Springdale, Arkansas
  • +10 more
Mar 16, 2021

Unusual Infiltrative Patterns of Malignant Cells in Endometrial

Not yet recruiting
  • Endometrial Cancer
    • (no location specified)
    Mar 11, 2023

    Diffuse Cutaneous Systemic Sclerosis Trial in London (Brentuximab Vedotin)

    Recruiting
    • Diffuse Cutaneous Systemic Sclerosis
    • Brentuximab Vedotin
    • London, Ontario, Canada
      Rheumatology Clinic, St. Joseph's Health Care
    Feb 3, 2022

    Breast Cancer, Gastric Cancer, Gastroesophageal-junction Cancer Trial in Australia (IKS014)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • Concord, New South Wales, Australia
    • +4 more
    May 30, 2023

    Advanced Solid Tumor Trial in China (7MW3711 for injection)

    Not yet recruiting
    • Advanced Solid Tumor
    • 7MW3711 for injection
    • Changsha, Hunan, China
    • +3 more
    Aug 18, 2023

    Advanced Solid Tumor Trial (7MW3711 for injection)

    Not yet recruiting
    • Advanced Solid Tumor
    • 7MW3711 for injection
    • (no location specified)
    Aug 18, 2023

    Carcinoma, Solid Tumor Trial in Suzhou (ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin)

    Not yet recruiting
    • Carcinoma
    • Solid Tumor
    • ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin
    • Suzhou, China
      Second Affiliated Hospital of Soochow University
    Oct 26, 2023

    Ovarian Cancer, Lung Adenocarcinoma Trial in United States (AZD5335, AZD5305)

    Not yet recruiting
    • Ovarian Cancer
    • Lung Adenocarcinoma
    • Duarte, California
    • +6 more
    Mar 21, 2023

    Advanced Malignant Tumor Trial in China (TQB2103 for injection)

    Not yet recruiting
    • Advanced Malignant Neoplasm
    • TQB2103 for injection
    • Zhengzhou, Henan, China
    • +3 more
    May 19, 2023

    Advanced Solid Tumor Trial (HS-20105)

    Not yet recruiting
    • Advanced Solid Tumor
    • (no location specified)
    Nov 17, 2023

    Her 2 Positive Breast Cancer, Breast Cancer Female, Breast Cancer Metastatic Trial in Boston (Sacituzumab Govitecan,

    Not yet recruiting
    • Her 2 Positive Breast Cancer
    • +2 more
    • Sacituzumab Govitecan
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Oct 25, 2023

    Advanced Solid Tumor Trial (HS-20093)

    Not yet recruiting
    • Advanced Solid Tumor
    • (no location specified)
    Oct 29, 2023

    Advanced Breast Cancer Trial (Disitamab vedotin)

    Not yet recruiting
    • Advanced Breast Cancer
    • Disitamab vedotin
    • (no location specified)
    Apr 16, 2023

    Breast Cancer Trial in Boston (Talazoparib, Sacituzumab Govitecan)

    Recruiting
    • Breast Cancer
    • Boston, Massachusetts
    • +1 more
    Jan 6, 2023

    Solid Tumor Trial in Belgium, Netherlands, United Kingdom (SYD985 + Niraparib)

    Active, not recruiting
    • Solid Tumor
    • SYD985 + Niraparib
    • Antwerp, Belgium
    • +5 more
    Jan 23, 2023

    Diffuse Cutaneous Systemic Sclerosis Trial (Brentuximab vedotin)

    Not yet recruiting
    • Diffuse Cutaneous Systemic Sclerosis
    • Brentuximab vedotin
    • (no location specified)
    Apr 11, 2022

    Relapsed or Refractory Multiple Myeloma Trial in Beijing, Guangzhou, Hangzhou (STI-6129)

    Not yet recruiting
    • Relapsed or Refractory Multiple Myeloma
    • STI-6129
    • Beijing, Beijing, China
    • +3 more
    Jan 9, 2023

    MDD Trial in Los Angeles (PDC-1421 Capsule)

    Not yet recruiting
    • Major Depressive Disorder
    • PDC-1421 Capsule
    • Los Angeles, California
      Cedars-Sinai Health System
    Jul 18, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

    Not yet recruiting
    • Ovarian Cancer
    • +3 more
    • Beijing, Beijing, China
      Lingying Wu
    Aug 22, 2023

    Epidemic Meningitis Trial (MCV4)

    Not yet recruiting
    • Epidemic Meningitis
    • MCV4
    • (no location specified)
    Jul 5, 2023